Defining intermediate-risk non-muscle-invasive bladder cancer

被引：0
|
作者：
S. Bruce Malkowicz
机构：
[1] Perelman School of Medicine,Division of Urology, Department of Surgery
[2] University of Pennsylvania,undefined
来源：
Nature Reviews Urology | 2014年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The pathology of intermediate-risk non-muscle-invasive bladder cancer is less well-defined than both high-risk and low-risk presentations of this disease. Recently reported guidelines seek to aid clinicians in classification of intermediate-risk patients, and also provide treatment recommendations for this subgroup.
引用
收藏
页码：430 / 432
页数：2
相关论文
共 50 条
  • [41] Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer
    Ahmadi, Niloufar
    Shafee, Hamid
    Moudi, Emaduddin
    ASIAN JOURNAL OF UROLOGY, 2024, 11 (04) : 625 - 632
  • [42] Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer
    Niloufar Ahmadi
    Hamid Shafee
    Emaduddin Moudi
    Asian Journal of Urology, 2024, 11 (04) : 625 - 632
  • [43] Treatment of high-risk, non-muscle-invasive bladder cancer
    Seth P Lerner
    Nature Clinical Practice Urology, 2006, 3 : 398 - 399
  • [44] Treatment of high-risk, non-muscle-invasive bladder cancer
    Lerner, Seth P.
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (08): : 398 - 399
  • [45] THERAPEUTIC EFFECT OF MITOMYCIN C IN THE IMMEDIATE POSTOPERATIVE PERIOD IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE-INVASIVE BLADDER TUMORS.
    Jalon, Monzon A.
    Fernandez, Gomez J. M.
    Escaf, Barmadah S.
    Alvarez, Mugica M.
    Martin, Benito J. L.
    Regadera, Sejas F. J.
    ACTAS UROLOGICAS ESPANOLAS, 2008, 32 (09): : 894 - 903
  • [46] Re: Prediction Model for Recurrence Probabilities after Intravesical Chemotherapy in Patients with Intermediate-Risk Non-Muscle-Invasive Bladder Cancer, Including External Validation
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2017, 198 (03): : 482 - 482
  • [47] Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer
    Russell, Beth
    Liedberg, Fredrik
    Hagberg, Oskar
    Ullen, Anders
    Soderkvist, Karin
    Strock, Viveka
    Aljabery, Firas
    Gardmark, Truls
    Jerlstrom, Tomas
    Sherif, Amir
    Holmberg, Lars
    Bryan, Richard T.
    Enting, Deborah
    Van Hemelrijck, Mieke
    SCANDINAVIAN JOURNAL OF UROLOGY, 2022, 56 (01) : 27 - 33
  • [48] Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer
    Russell, B.
    Leidberg, F.
    Hagberg, O.
    Ullen, A.
    Soderkvist, K.
    Strock, V.
    Aljabery, F.
    Gardmark, T.
    Jerlstrom, T.
    Sherif, A.
    Holmberg, L.
    Bryan, R. T.
    Enting, D.
    Van Hemelrijck, M.
    EUROPEAN UROLOGY, 2021, 79 : S1014 - S1015
  • [49] Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs
    Grabe-Heyne, Kristin
    Henne, Christof
    Mariappan, Paramananthan
    Geiges, Gotz
    Poehlmann, Johannes
    Pollock, Richard F.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [50] Recirculant hyperthermic IntraVEsical chemotherapy (HIVEC) in intermediate-high-risk non-muscle-invasive bladder cancer
    Sousa, Alejandro
    Pineiro, Idelfonso
    Rodriguez, Silvia
    Aparici, Vicente
    Monserrat, Victor
    Neira, Pilar
    Carro, Enrique
    Murias, Carmen
    Uribarri, Carlos
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2016, 32 (04) : 374 - 380
12345